<?xml version="1.0" encoding="UTF-8"?>
<p id="Par1487">This study is being conducted through the Innovative Medicines Initiative Joint Undertaking in the EU and is a joint collaboration between Medimmune and the academic partners within the Combatting Bacterial Resistance in Europe â€“ Molecules against Gram Negative Infections (COMBACTE-MAGNET), which is a consortium of experts in the field of antibiotic-resistant bacteria and ventilator-associated pneumonia.</p>
